Durham, United States
Cell Microsystems, founded in 2010, operates within the Biotechnology and Life Sciences industries, with its headquarters in the United States. The company harnesses transformative platforms for cell engineering, culture, and analysis, as encapsulated in its slogan: "Harness the Power of Cells: Transformative platforms for cell engineering, culture, and analysis."
The product lineup, including the CellRaft AIR System, BioFlux Shear Flow Systems, and CERO 3D Cell Culture & Bioreactor, reveals a strategic focus on empowering laboratories to explore new frontiers in cellular research and discovery. These technological offerings support the growth and isolation of healthy colonies and emulate in vivo conditions, representing substantial advancements in organoid growth and 3D cultures.
In its recent financial activities, Cell Microsystems secured a $6.50M Series B investment on 23 August 2023 from Telegraph Hill Partners. This funding underscores investor confidence and the company's potential to drive innovation in its fields of expertise.
